GB0129059D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0129059D0
GB0129059D0 GB0129059A GB0129059A GB0129059D0 GB 0129059 D0 GB0129059 D0 GB 0129059D0 GB 0129059 A GB0129059 A GB 0129059A GB 0129059 A GB0129059 A GB 0129059A GB 0129059 D0 GB0129059 D0 GB 0129059D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0129059A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0129059A priority Critical patent/GB0129059D0/en
Publication of GB0129059D0 publication Critical patent/GB0129059D0/en
Priority to CNB028263847A priority patent/CN100343238C/en
Priority to IL16161902A priority patent/IL161619A0/en
Priority to JP2003542154A priority patent/JP2005515176A/en
Priority to MXPA04004219A priority patent/MXPA04004219A/en
Priority to DE60231230T priority patent/DE60231230D1/en
Priority to AT02774960T priority patent/ATE423104T1/en
Priority to BR0213842-5A priority patent/BR0213842A/en
Priority to US10/494,137 priority patent/US20050043336A1/en
Priority to EP02774960A priority patent/EP1444210B1/en
Priority to NZ532524A priority patent/NZ532524A/en
Priority to RU2004116911/04A priority patent/RU2004116911A/en
Priority to ES02774960T priority patent/ES2320980T3/en
Priority to PCT/GB2002/004931 priority patent/WO2003040108A1/en
Priority to HU0401646A priority patent/HUP0401646A2/en
Priority to PL02369938A priority patent/PL369938A1/en
Priority to KR1020047006709A priority patent/KR20050042055A/en
Priority to CA002465068A priority patent/CA2465068A1/en
Priority to TW091132367A priority patent/TW200301702A/en
Priority to ARP020104181A priority patent/AR037330A1/en
Priority to IS7240A priority patent/IS7240A/en
Priority to CO04051621A priority patent/CO5580774A2/en
Priority to NO20042279A priority patent/NO20042279L/en
Priority to HK04109119.3A priority patent/HK1066218A1/en
Priority to US11/443,208 priority patent/US20070082921A1/en
Ceased legal-status Critical Current

Links

GB0129059A 2001-11-03 2001-12-05 Compounds Ceased GB0129059D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB0129059A GB0129059D0 (en) 2001-12-05 2001-12-05 Compounds
CA002465068A CA2465068A1 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
ES02774960T ES2320980T3 (en) 2001-11-03 2002-10-31 DERIVATIVES OF QUINAZOLINA AS ANTITUMOR AGENTS.
HU0401646A HUP0401646A2 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents, process for their preparation and pharmaceutical compositions containing them
JP2003542154A JP2005515176A (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
MXPA04004219A MXPA04004219A (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents.
DE60231230T DE60231230D1 (en) 2001-11-03 2002-10-31 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS
AT02774960T ATE423104T1 (en) 2001-11-03 2002-10-31 QUINAZOLINE DERIVATIVES AS ANTI-TUMOR AGENT
BR0213842-5A BR0213842A (en) 2001-11-03 2002-10-31 Quinazoline derivative or a pharmaceutically acceptable salt thereof, process for preparing the same, pharmaceutical composition, and use of the quinazoline derivative or pharmaceutically acceptable salt thereof
US10/494,137 US20050043336A1 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
EP02774960A EP1444210B1 (en) 2001-11-03 2002-10-31 Qunazoline derivatives as antitumor agents
NZ532524A NZ532524A (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
RU2004116911/04A RU2004116911A (en) 2001-11-03 2002-10-31 Quinazoline derivatives as anti-tumor agents
CNB028263847A CN100343238C (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
PCT/GB2002/004931 WO2003040108A1 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
IL16161902A IL161619A0 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
PL02369938A PL369938A1 (en) 2001-11-03 2002-10-31 Quinazoline derivatives as antitumor agents
KR1020047006709A KR20050042055A (en) 2001-11-03 2002-10-31 Quinazoline derivaives as antitumor agents
ARP020104181A AR037330A1 (en) 2001-11-03 2002-11-01 DERIVATIVE OF QUINAZOLINE, PHARMACEUTICAL COMPOSITION, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE SUCH DERIVATIVE OF QUINAZOLINE
TW091132367A TW200301702A (en) 2001-11-03 2002-11-01 Quinazoline derivatives
IS7240A IS7240A (en) 2001-11-03 2004-04-30 Quinazoline derivatives as anti-tumor agents
CO04051621A CO5580774A2 (en) 2001-11-03 2004-06-02 DERIVATIVES OF QUINAZOLINE AS ANTINEOPLASIC AGENTS
NO20042279A NO20042279L (en) 2001-11-03 2004-06-02 Quinazoline derivatives as antitumor agents
HK04109119.3A HK1066218A1 (en) 2001-11-03 2004-11-18 Qunazoline derivatives as antitumor agents
US11/443,208 US20070082921A1 (en) 2001-11-03 2006-05-31 Quinazoline derivatives as antitumor agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0129059A GB0129059D0 (en) 2001-12-05 2001-12-05 Compounds

Publications (1)

Publication Number Publication Date
GB0129059D0 true GB0129059D0 (en) 2002-01-23

Family

ID=9927005

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0129059A Ceased GB0129059D0 (en) 2001-11-03 2001-12-05 Compounds

Country Status (1)

Country Link
GB (1) GB0129059D0 (en)

Similar Documents

Publication Publication Date Title
GB0101996D0 (en) Organtic compounds
GB0112324D0 (en) Compounds
GB0102668D0 (en) Compounds
GB0121488D0 (en) Compounds
GB0108102D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0119472D0 (en) Compounds
EP1458669A4 (en) Neuorologically-active compounds
GB0118364D0 (en) Compounds
GB0115178D0 (en) Compounds
GB0119473D0 (en) Compounds
GB0108097D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0105098D0 (en) Compounds
GB0115438D0 (en) Compounds
GB0121303D0 (en) Compounds
GB0118994D0 (en) Compounds
GB0129059D0 (en) Compounds
GB0116781D0 (en) Compounds
GB0116059D0 (en) Compounds
GB0115863D0 (en) Compounds
GB0119424D0 (en) Compounds
GB0120321D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)